EarningsQ4 2022 Earnings Report

Recursion Pharmaceuticals (RXRX) Q4 2022 Earnings Report

7 Followers

MX:RXRX Q4 2022 EPS Results

Actual EPS-$5.63

Consensus EPS-$5.27

Beat/MissMissed by -$0.36

One Year Ago EPS-$6.90

Actual Revenue$248.37M

Expected Revenue$432.22M

Beat/MissMissed by -$183.86M

YoY Revenue Growth+439.91%

QuarterQ4 2022

Date02/27/2023

TimeAfter Close

Conference CallMonday, February 27, 2023

MX:RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-4.00 / -	-6.538	―
Aug 05, 2026	2026 (Q2)	-4.36 / -4.54	-7.446	39.02% (+2.91)
May 06, 2026	2026 (Q1)	-4.81 / -4.00	-9.08	56.00% (+5.08)
Feb 25, 2026	2025 (Q4)	-5.47 / -3.81	-9.625	60.38% (+5.81)
Nov 05, 2025	2025 (Q3)	-6.85 / -6.54	-6.175	-5.88% (-0.36)
Aug 05, 2025	2025 (Q2)	-6.41 / -7.45	-7.264	-2.50% (-0.18)
May 05, 2025	2025 (Q1)	-9.37 / -9.08	-7.083	-28.21% (-2.00)
Feb 28, 2025	2024 (Q4)	-7.46 / -9.63	-7.627	-26.19% (-2.00)
Nov 06, 2024	2024 (Q3)	-6.05 / -6.17	-7.809	20.93% (+1.63)
Aug 08, 2024	2024 (Q2)	-6.97 / -7.26	-6.901	-5.26% (-0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed